Nader El-Sayes

758 total citations
13 papers, 504 citations indexed

About

Nader El-Sayes is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Nader El-Sayes has authored 13 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Immunology and 5 papers in Genetics. Recurrent topics in Nader El-Sayes's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Virus-based gene therapy research (5 papers). Nader El-Sayes is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Virus-based gene therapy research (5 papers). Nader El-Sayes collaborates with scholars based in Canada, United States and United Kingdom. Nader El-Sayes's co-authors include Karen Mossman, Alyssa Vito, Yonghong Wan, Fanny Tzelepis, Andrew Chen, John C. Bell, Mohammed Selman, Samuel T. Workenhe, Ramya Krishnan and Fabrice Le Bœuf and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Therapy and Cells.

In The Last Decade

Nader El-Sayes

12 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nader El-Sayes Canada 10 218 186 165 136 68 13 504
Alyssa Vito Canada 11 210 1.0× 204 1.1× 146 0.9× 139 1.0× 95 1.4× 18 555
Joanna Obacz United States 12 86 0.4× 311 1.7× 77 0.5× 116 0.9× 27 0.4× 15 610
Suchandrima Saha United States 7 171 0.8× 343 1.8× 195 1.2× 161 1.2× 37 0.5× 13 573
Gitanjali Jayachandran United States 11 159 0.7× 338 1.8× 61 0.4× 109 0.8× 65 1.0× 27 522
Yuan‐Tong Liu China 14 384 1.8× 319 1.7× 365 2.2× 136 1.0× 193 2.8× 18 894
Neha Papneja Canada 2 370 1.7× 237 1.3× 271 1.6× 86 0.6× 129 1.9× 4 723
Fathema Uddin United States 5 224 1.0× 498 2.7× 76 0.5× 120 0.9× 21 0.3× 7 727
Liuliu Yang China 14 75 0.3× 605 3.3× 152 0.9× 415 3.1× 39 0.6× 27 885
Chad A. Komar United States 3 260 1.2× 155 0.8× 200 1.2× 52 0.4× 75 1.1× 5 462

Countries citing papers authored by Nader El-Sayes

Since Specialization
Citations

This map shows the geographic impact of Nader El-Sayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nader El-Sayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nader El-Sayes more than expected).

Fields of papers citing papers by Nader El-Sayes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nader El-Sayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nader El-Sayes. The network helps show where Nader El-Sayes may publish in the future.

Co-authorship network of co-authors of Nader El-Sayes

This figure shows the co-authorship network connecting the top 25 collaborators of Nader El-Sayes. A scholar is included among the top collaborators of Nader El-Sayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nader El-Sayes. Nader El-Sayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Walsh, Scott R., Andrew Nguyen, Lan Chen, et al.. (2024). Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T Cells. Cancer Immunology Research. 13(1). 84–97.
2.
Vito, Alyssa, Nader El-Sayes, Susan E. Collins, et al.. (2023). Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells. Cancers. 15(4). 1295–1295. 10 indexed citations
3.
El-Sayes, Nader, Scott R. Walsh, Alyssa Vito, et al.. (2022). IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity. Molecular Therapy — Oncolytics. 25. 16–30. 13 indexed citations
4.
El-Sayes, Nader, Alyssa Vito, Omar Salem, et al.. (2022). A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner. International Journal of Molecular Sciences. 23(3). 1754–1754. 11 indexed citations
5.
Vito, Alyssa, Omar Salem, Nader El-Sayes, et al.. (2021). Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells. Communications Biology. 4(1). 859–859. 16 indexed citations
6.
El-Sayes, Nader, Alyssa Vito, & Karen Mossman. (2021). Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy. Cancers. 13(4). 806–806. 118 indexed citations
7.
El-Sayes, Nader, et al.. (2021). Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells. International Journal of Molecular Sciences. 22(9). 4893–4893. 17 indexed citations
8.
Vito, Alyssa, et al.. (2021). Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer. International Journal of Molecular Sciences. 22(9). 4843–4843. 1 indexed citations
9.
Vito, Alyssa, Nader El-Sayes, Omar Salem, Yonghong Wan, & Karen Mossman. (2021). Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer. Cancers. 13(21). 5590–5590. 3 indexed citations
10.
Workenhe, Samuel T., Andrew Nguyen, David Bakhshinyan, et al.. (2020). De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors. Communications Biology. 3(1). 645–645. 41 indexed citations
11.
Vito, Alyssa, Nader El-Sayes, & Karen Mossman. (2020). Hypoxia-Driven Immune Escape in the Tumor Microenvironment. Cells. 9(4). 992–992. 189 indexed citations
12.
Fergusson, Dean, Justin Presseau, Kelly D. Cobey, et al.. (2019). Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies. Molecular Therapy — Oncolytics. 14. 179–187. 12 indexed citations
13.
Selman, Mohammed, Ramya Krishnan, Nader El-Sayes, et al.. (2017). Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds. Molecular Therapy. 26(1). 56–69. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alyssa Vito Breakdown of academic impact, for papers by Joanna Obacz Breakdown of academic impact, for papers by Suchandrima Saha Breakdown of academic impact, for papers by Gitanjali Jayachandran Breakdown of academic impact, for papers by Yuan‐Tong Liu Breakdown of academic impact, for papers by Neha Papneja Breakdown of academic impact, for papers by Fathema Uddin Breakdown of academic impact, for papers by Liuliu Yang Breakdown of academic impact, for papers by Chad A. Komar
Rankless by CCL
2026